Skip to content

Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease

Post-Market, Long-Term Follow Up of Mobi-C® Cervical Disc for One and Two Level Treatment of Cervical Disc Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03077516
Enrollment
216
Registered
2017-03-13
Start date
2016-11-30
Completion date
2019-10-31
Last updated
2019-12-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Disc Degeneration, Cervical Disc Disease

Brief summary

The purpose of this study is to evaluate clinical and patient-reported outcomes at 10 years following surgery for a cohort of Mobi-C subjects treated on the IDE/Post Approval studies

Detailed description

This is a prospective, multi-center, consecutive cohort study. Subjects invited to participate in this study will have completed the Mobi-C IDE study (G050212). In this study, five hundred and seventy-five subjects were randomized to either the Mobi-C prosthesis or the control treatment - conventional anterior cervical discectomy and fusion (ACDF) with anterior cervical plating. The study was randomized in a 2 to 1 ratio (two Mobi-C subjects for every one subject receiving ACDF with anterior cervical plate). The subject retention rate for Mobi-C subjects was 80.1% (1 level)-84.4% (2 level) at 7 years. As non-inferiority (1-level) and superiority (2-level) have been well established through 7 years, the design of this study will focus on the long-term outcomes of a cohort of the Mobi-C arm of the study and evaluate the durability of outcomes at 10 years. Study sites invited to participate will be those that enrolled at least 10 subjects, and also had the highest retention rates at 7 years (≥70%). All subjects at these sites will be contacted to participate in an additional 10 year follow up visit. It is estimated that up to 250 subjects will be enrolled at 9-12 study sites. Certain endpoints are better assessed in comparison to the control ACDF arm, such as adjacent segment degeneration and subsequent surgery. This study has been amended to include a subset of sites that will also enroll control subjects. Up to 3 sites and 50 subjects will be included in this control cohort.

Interventions

DEVICEMobi-C

Device for cervical intervertebral disc replacement at one or two contiguous levels

Sponsors

LDR Spine USA
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Prior enrollment in LDR-001 Pivotal Study (IDE G050212); 2. Written informed consent provided by subject or subject's legally authorized representative

Exclusion criteria

1. Documented withdrawal of consent from prior Mobi-C study; 2. Documented non-compliance (including unwillingness to return to the site for follow-up visits) 3. Reported pregnancy at time of enrollment, or with plans to become pregnant prior to completing study X-Rays

Design outcomes

Primary

MeasureTime frame
NDI Score10 Years

Secondary

MeasureTime frameDescription
Neck Pain/Arm Pain VAS10 Year
QOL SF-1210 Year
Patient Satisfaction10 YearMeasured by a two questions scale that includes ranking of level of satisfaction and willingness to recommend treatment.
Secondary surgery Rate10 Years
Device related complications10 Years
Overall Success10 YearComposite score composed of: 1) NDI improvement of at least 15 points (out of 50) from baseline; 2) No subsequent surgical intervention at the index level or levels; 3) No potentially (possibly or probably) device-related adverse event; 4) Maintenance or improvement in all components of neurologic status; and 5) No Mobi-C intraoperative changes in treatment.
Range of motion10 YearsRadiographically measured angle, in degrees, between endplates of adjacent vertebrae
Disc Height10 YearsRadiographically measured distance, in mm, from corner of superior vertebra to corresponding corner of inferior vertebra
Heterotopic Ossification10 YearsQualitative radiographic assessment using McAfee grading system, grades 1-4
Adjacent Segment Degeneration10 YearsQualitative radiographic assessment using Kellgren-Lawrence Disc Degeneration Grading, grades 0-IV
Device displacement or migration10 YearRadiographic assessment of movement of device from original placement

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026